NCT04776525

Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2021-04-27Est. Completion: 2027-12

Enrollment target: 49 participants

Locations

Contact

Non-small Cell Lung Cancer

This is a study evaluating the efficacy and safety of calderasib with pembrolizumab as first-line treatment in participa…

Bakersfield, United StatesEst. completion Jan 24, 2028

HLA-A*0201 Positive Cells PresentClear Cell Sarcoma (CCS)

This is a multi-center, open label, phase II study of tebentafusp in patients with unresectable or metastatic clear cell…

Los Angeles, United StatesEst. completion Oct 1, 2030

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.